Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis

NCT02217475 is registered in ClinicalTrials.gov with Tobira Therapeutics, Inc. as lead sponsor.

NCT NCT02217475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02217475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Lead sponsor
Tobira Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 18, 2014
Completion date
June 22, 2017
Enrollment
289 (actual)
Sites
91

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis